Danaher Corporation designs, manufactures, and markets a variety of professional, medical, industrial, and commercial products and services globally. The company operates through three primary segments: Life Sciences (approximately 45% of revenue), Diagnostics (about 40%), and Environmental & Applied Solutions (around 15%). Revenue is generated from a diverse customer base, including pharmaceutical and biopharmaceutical companies, hospitals, reference laboratories, and industrial manufacturers. Factors supporting Danaher's endurance include its broad product portfolio and established customer relationships, while potential limitations may arise from regulatory changes and competition in the healthcare and industrial sectors.
—
Danaher Corporation designs, manufactures, and markets a variety of professional, medical, industrial, and commercial products and services globally. The company operates through three primary segments: Life Sciences (approximately 45% of revenue), Diagnostics (about 40%), and Environmental & Applied Solutions (around 15%). Revenue is generated from a diverse customer base, including pharmaceutical and biopharmaceutical companies, hospitals, reference laboratories, and industrial manufacturers. Factors supporting Danaher's endurance include its broad product portfolio and established customer relationships, while potential limitations may arise from regulatory changes and competition in the healthcare and industrial sectors.
—
Daily adjusted close
Danaher Corporation designs, manufactures, and markets a variety of professional, medical, industrial, and commercial products and services globally. The company operates through three primary segments: Life Sciences (approximately 45% of revenue), Diagnostics (about 40%), and Environmental & Applied Solutions (around 15%). Revenue is generated from a diverse customer base, including pharmaceutical and biopharmaceutical companies, hospitals, reference laboratories, and industrial manufacturers. Factors supporting Danaher's endurance include its broad product portfolio and established customer relationships, while potential limitations may arise from regulatory changes and competition in the healthcare and industrial sectors.